Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER_GOV 2OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2Prostate Adenocarcinoma 1Liver Neoplasms 1

Interventions

tislelizumab 4Sorafenib 3Propranolol 3ledipasvir 2entecavir 2donafenib 2apatinib 2Sofosbuvir 2Ribavirin 2Radiotherapy 2Proton Therapy 2Bevacizumab 2sitravatinib 1polysaccharide MGN3 1palbociclib 1lenvatinib 1lens intermediate filament proteins 1ledipasvir, sofosbuvir drug combination 1envafolimab 1elbasvir-grazoprevir drug combination 1daclatasvir 1camrelizumab 1atezolizumab 1anlotinib 1Vitamin D 1Urination 1Tyrosine Kinase Inhibitors 1Surgical Procedures, Operative 1Simeprevir 1Raltegravir Potassium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Carcinoma, Hepatocellular × Proton Therapy × Clear all
NCT02395523 2020-07-07

Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma

National Cancer Center, Korea

Phase NA Completed
45 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01643824 2018-08-23

Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma

National Cancer Center, Korea

Phase NA Completed
112 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡